“…The NK2r antagonists MEN10376 and GR94800 reduced the tetrodotoxin-sensitive spontaneous motility of the circular muscle layer (Cao et al, 2004b). In the circular muscle layer the NK2r antagonist SR48968 greatly decreases the atropine-sensitive EFS-induced contractions, suggesting that NK2r might be involved in the prejunctional neuronal cholinergic processes modulating colonic motility (Stanton et al, 2003;Maselli et al, 2004). The results of many pharmacological studies have combined to show that TKs-induced contraction via NK2r is reduced in patients affected by constipation, diverticulosis, and inflammatory bowel disease (Al-Saffar and Hellstrom, 2001;Liu et al, 2002;Cao et al, 2004a,b; for reviews, see Lecci et al, 2004Lecci et al, , 2006.…”